These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9546691)

  • 1. Urinary transforming growth factor-beta (TGF-beta) excretion and renal production of TGF-beta in rats with subtotal renal ablation: effect of enalapril and nifedipine.
    Monteiro de Freitas AS; Coimbra TM; Costa RS; Baroni EA
    Nephron; 1998; 78(3):302-9. PubMed ID: 9546691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
    Volpini RA; da Silva CG; Costa RS; Coimbra TM
    Diabetes Metab Res Rev; 2003; 19(1):43-51. PubMed ID: 12592643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A
    Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats.
    Noda M; Fukuda R; Matsuo T; Ohta M; Nagano H; Imura Y; Nishikawa K; Shibouta Y
    Kidney Int Suppl; 1997 Dec; 63():S136-9. PubMed ID: 9407442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta production during the development of renal fibrosis in rats with subtotal renal ablation.
    Coimbra TM; Carvalho J; Fattori A; Da Silva CG; Lachat JJ
    Int J Exp Pathol; 1996 Aug; 77(4):167-73. PubMed ID: 8943735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms.
    Dworkin LD; Benstein JA; Parker M; Tolbert E; Feiner HD
    Kidney Int; 1993 Apr; 43(4):808-14. PubMed ID: 8479116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary cytokine profiles according to the site of blockade of the renin-angiotensin system in nephrectomized rats.
    Baracho NCDV; Silveira KDD; Rocha NP; Cordeiro TM; Feracin V; Pereira RM; Reis MAAD; Teixeira MM; Silva ACSE
    J Bras Nefrol; 2017; 39(2):108-118. PubMed ID: 29069238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of enalapril on glomerular growth and glomerular lesions after subtotal nephrectomy in the rat: a stereological analysis.
    Amann K; Irzyniec T; Mall G; Ritz E
    J Hypertens; 1993 Sep; 11(9):969-75. PubMed ID: 8254179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of treatment with angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor antagonist (AIIRA) on renal function and glomerular injury in subtotal nephrectomized rats.
    Yamamoto M; Fukui M; Shou I; Wang LN; Sekizuka K; Suzuki S; Shirato I; Tomino Y
    J Clin Lab Anal; 1997; 11(1):53-62. PubMed ID: 9021525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibition attenuates proteinuria and renal TGF-beta 1 mRNA expression in rats with chronic renal disease.
    Ali SM; Laping NJ; Fredrickson TA; Contino LC; Olson Ba; Anderson K; Brooks DP
    Pharmacology; 1998 Jul; 57(1):20-7. PubMed ID: 9670209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat.
    Jackson B; Cubela R; Debrevi L; Whitty M; Johnston CI
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S167-9. PubMed ID: 2455124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The expression of connective tissue growth factor in renal cortex of 5/6 nephrectomized rats and its modulation by fluvastatin].
    Song GW; Li C; Zheng YC; Kong J; Sun B
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(16):1428-32. PubMed ID: 14521748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats.
    Adamczak M; Gross ML; Krtil J; Koch A; Tyralla K; Amann K; Ritz E
    J Am Soc Nephrol; 2003 Nov; 14(11):2833-42. PubMed ID: 14569093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerulosclerosis and progression: effect of subantihypertensive doses of alpha and beta blockers.
    Amann K; Koch A; Hofstetter J; Gross ML; Haas C; Orth SR; Ehmke H; Rump LC; Ritz E
    Kidney Int; 2001 Oct; 60(4):1309-23. PubMed ID: 11576345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin converting enzyme inhibitor suppresses glomerular transforming growth factor beta receptor expression in experimental diabetes in rats.
    Hill C; Logan A; Smith C; Grønbaek H; Flyvbjerg A
    Diabetologia; 2001 Apr; 44(4):495-500. PubMed ID: 11357481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.
    Mizobuchi M; Morrissey J; Finch JL; Martin DR; Liapis H; Akizawa T; Slatopolsky E
    J Am Soc Nephrol; 2007 Jun; 18(6):1796-806. PubMed ID: 17513326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
    Chan JC; Ko GT; Leung DH; Cheung RC; Cheung MY; So WY; Swaminathan R; Nicholls MG; Critchley JA; Cockram CS
    Kidney Int; 2000 Feb; 57(2):590-600. PubMed ID: 10652036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms underlying renoprotection during renin-angiotensin system blockade.
    Taal MW; Chertow GM; Rennke HG; Gurnani A; Jiang T; Shahsafaei A; Troy JL; Brenner BM; Mackenzie HS
    Am J Physiol Renal Physiol; 2001 Feb; 280(2):F343-55. PubMed ID: 11208610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats.
    Wang JL; Cheng HF; Shappell S; Harris RC
    Kidney Int; 2000 Jun; 57(6):2334-42. PubMed ID: 10844603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.